Patent 8642076 was granted and assigned to Tekmira Pharmaceuticals Corporation on February, 2014 by the United States Patent and Trademark Office.
Compositions and methods useful in administering nucleic acid based therapies, for example association complexes such as liposomes and lipoplexes are described.